CVS Health (NYSE:CVS) Releases FY22 Earnings Guidance
CVS Health (NYSE:CVS – Get Rating) updated its FY22 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $8.20-8.40 for the period, compared to the consensus estimate of $8.41. CVS Health also updated its FY 2022 guidance to $8.20-$8.40 EPS. Shares of CVS stock traded up $0.23 during trading hours on […]